PrEP daily will tell you, remembering to take it can be a chore. Injectable PrEP is now available but only a small number of men are using it.
We’re sure most daily users would jump at the chance of switching to a once-a-week pill.It appears a race is now on to get such a pill to the market.
The CDC recently announced encouraging results from studies of a new, once-a-week PrEP tablet. It contains tenofovir alafenamide (TAF).
This is a newer formulation of tenofovir disoproxil (TDF), the drug found in Truvada. TAF is already used and is known to have fewer side effects on the kidneys.